Melzer Cohen, Cheli http://orcid.org/0000-0001-9033-4108
Hallén, Nino
Chodick, Gabriel
Bourvine, Lotmit
Waner, Tal
Karasik, Avraham
Funding for this research was provided by:
Novo Nordisk A/S
Article History
Accepted: 12 April 2021
First Online: 27 April 2021
Declarations
:
: This study and the article processing charges were funded by Novo Nordisk A/S.
: CMC and GC have no conflict of interest to report. NH, LB and TW are all employees of Novo Nordisk. AK has received research grants, honoraria for lectures and consulting fees from Novo Nordisk.
: The study design was approved by the Maccabi Healthcare Services’ Institutional Review Board.
: Individual patient consent was not required due to the anonymised nature of the Maccabi Healthcare Services’ database.
: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
: None of the authors have a related or duplicate manuscript under consideration or accepted for publication elsewhere.
: Some parts of this study were presented as a poster at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, 16–19 November 2020.
: CMC is the guarantor of this work and, as such, had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors confirm that they meet the International Committee of Medical Journal Editors (ICJME) uniform requirements for authorship and that they have contributed to critical analysis and interpretation of the data, drafting and/or critically revising the article and sharing in the final responsibility for the content of the manuscript, as well as the decision to submit it for publication.